Allogene Therapeutics, Inc. (ALLO) vs Fate Therapeutics, Inc. (FATE)
Detailed comparison between Allogene Therapeutics, Inc., Fate Therapeutics, Inc..Total Return (%)
Allogene Therapeutics, Inc. (ALLO)Fate Therapeutics, Inc. (FATE)
Which stock do you think will perform better?
Allogene Therapeutics, Inc.
ALLO
Fate Therapeutics, Inc.
FATE
| Metric | Allogene Therapeutics, Inc. (ALLO) | Fate Therapeutics, Inc. (FATE) |
|---|---|---|
| Current Price | $1.45 | $1.11 |
| Change | 0.05 (3.57%) | 0.06 (5.71%) |
| Market Cap | $0.32B | $0.13B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -1.04 | -0.66 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $3.78 | $5.92 |
| 52-Week Low | $1.23 | $0.66 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-1.32 | $-1.64 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| ALLO | -10.49% | -21.20% | -57.35% | -94.43% | -94.20% | -94.20% |
| FATE | 21.98% | -15.91% | -76.78% | -96.19% | -82.63% | -83.43% |